Chunzhang Wu
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 9
- Parasitic Diseases Research and Treatment 2
- Oncology top 5%
- Epidemiology top 5%
- Fungal Infections and Studies 5
- Surgery top 5%
- Urinary and Genital Oncology Studies 16
- Bladder and Urothelial Cancer Treatments 16
- Esophageal Cancer Research and Treatment 4
-
- Cancer Research and Treatments 3
-
- Cystic Fibrosis Research Advances 2
- Co-authors
- Jonathan E. RosenbergDaniel P. PetrylakThomas PowlesMary S. CampbellMaria MatsangouNobuaki MatsubaraYohann LoriotGuru Sonpavde
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (9 papers)Cancer Research (1 paper)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Chunzhang Wu
28 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Infectious Diseases 831
- Applied Microbiology and Biotechnology 78
- Oncology 661
- Epidemiology 670
- Surgery 804
Countries citing papers authored by Chunzhang Wu
This map shows the geographic impact of Chunzhang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunzhang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunzhang Wu more than expected).
Fields of papers citing papers by Chunzhang Wu
This network shows the impact of papers produced by Chunzhang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunzhang Wu. The network helps show where Chunzhang Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chunzhang Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinomabreakdown → | 2023 | 84 |
| 2 | 2022 | 2 | |
| 3 | 2021 | 0 | |
| 4 | Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinomabreakdown → | 2021 | 670 |
| 5 | 2021 | 2 | |
| 6 | 2021 | 10 | |
| 7 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinomabreakdown → | 2020 | 223 |
| 8 | 2020 | 11 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 2 | |
| 11 | 2019 | 14 | |
| 12 | 2018 | 33 | |
| 13 | 2018 | 27 | |
| 14 | 2018 | 6 | |
| 15 | 2014 | 29 | |
| 16 | 2013 | 14 | |
| 17 | 2010 | 169 | |
| 18 | 2009 | 52 | |
| 19 | Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (vol 45, pg 883, 2007) | 2008 | 108 |
| 20 | Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasisbreakdown → | 2007 | 478 |
About Chunzhang Wu
Chunzhang Wu is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Surgery, having authored 29 papers that have together received 2.0k indexed citations. Recurring topics across this work include Urinary and Genital Oncology Studies (16 papers), Bladder and Urothelial Cancer Treatments (16 papers), Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (5 papers), Esophageal Cancer Research and Treatment (4 papers), Cancer Research and Treatments (3 papers), Parasitic Diseases Research and Treatment (2 papers) and Cystic Fibrosis Research Advances (2 papers). The work is most often cited by research in Infectious Diseases (831 citations), Applied Microbiology and Biotechnology (78 citations) and Oncology (661 citations). Chunzhang Wu has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Jonathan E. Rosenberg, Daniel P. Petrylak, Thomas Powles, Mary S. Campbell, Maria Matsangou, Nobuaki Matsubara, Yohann Loriot, Guru Sonpavde, Ignacio Durán and Christof Vulsteke. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.